{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-04-28", "results": { "skip": 0, "limit": 1, "total": 63110 } }, "results": [ { "safetyreportversion": "2", "safetyreportid": "10004008", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "1", "serious": "2", "receivedateformat": "102", "receivedate": "20140312", "receiptdateformat": "102", "receiptdate": "20140312", "fulfillexpeditecriteria": "2", "companynumb": "US-INCYTE CORPORATION-2013IN003026", "duplicate": "1", "reportduplicate": { "duplicatesource": "INCYTE", "duplicatenumb": "US-INCYTE CORPORATION-2013IN003026" }, "primarysource": { "reportercountry": "US", "qualification": "5" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "66", "patientonsetageunit": "801", "patientsex": "2", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Hypothyroidism", "reactionoutcome": "1" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Night sweats", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Fatigue", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Blood count abnormal", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "JAKAFI", "drugstructuredosagenumb": "15", "drugstructuredosageunit": "003", "drugcumulativedosagenumb": "6540", "drugcumulativedosageunit": "003", "drugdosagetext": "15 MG, BID", "drugdosageform": "TABLET", "drugadministrationroute": "048", "drugindication": "MYELOFIBROSIS", "drugstartdateformat": "102", "drugstartdate": "20121030", "drugenddateformat": "610", "drugenddate": "201308", "actiondrug": "3", "openfda": { "application_number": [ "NDA202192" ], "brand_name": [ "JAKAFI" ], "generic_name": [ "RUXOLITINIB" ], "manufacturer_name": [ "Incyte Corporation" ], "product_ndc": [ "50881-005", "50881-010", "50881-015", "50881-020", "50881-025" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "RUXOLITINIB" ], "rxcui": [ "1193331", "1193337", "1193339", "1193341", "1193343", "1193345", "1193347", "1193349", "1193351", "1193353" ], "spl_id": [ "3b1ce049-1571-4d2d-add5-a046496204d6" ], "spl_set_id": [ "f1c82580-87ae-11e0-bc84-0002a5d5c51b" ], "package_ndc": [ "50881-005-60", "50881-010-01", "50881-010-60", "50881-015-60", "50881-020-60", "50881-025-60" ], "nui": [ "N0000175605", "N0000190858", "N0000190857" ], "pharm_class_epc": [ "Kinase Inhibitor [EPC]", "Janus Kinase Inhibitor [EPC]" ], "pharm_class_moa": [ "Janus Kinase Inhibitors [MoA]" ], "unii": [ "82S8X8XX8H" ] } }, { "drugcharacterization": "1", "medicinalproduct": "JAKAFI", "drugstructuredosagenumb": "20", "drugstructuredosageunit": "003", "drugcumulativedosagenumb": "6540", "drugcumulativedosageunit": "003", "drugdosagetext": "20 MG, BID", "drugdosageform": "TABLET", "drugadministrationroute": "048", "drugstartdateformat": "102", "drugstartdate": "20130823", "actiondrug": "3", "openfda": { "application_number": [ "NDA202192" ], "brand_name": [ "JAKAFI" ], "generic_name": [ "RUXOLITINIB" ], "manufacturer_name": [ "Incyte Corporation" ], "product_ndc": [ "50881-005", "50881-010", "50881-015", "50881-020", "50881-025" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "RUXOLITINIB" ], "rxcui": [ "1193331", "1193337", "1193339", "1193341", "1193343", "1193345", "1193347", "1193349", "1193351", "1193353" ], "spl_id": [ "3b1ce049-1571-4d2d-add5-a046496204d6" ], "spl_set_id": [ "f1c82580-87ae-11e0-bc84-0002a5d5c51b" ], "package_ndc": [ "50881-005-60", "50881-010-01", "50881-010-60", "50881-015-60", "50881-020-60", "50881-025-60" ], "nui": [ "N0000175605", "N0000190858", "N0000190857" ], "pharm_class_epc": [ "Kinase Inhibitor [EPC]", "Janus Kinase Inhibitor [EPC]" ], "pharm_class_moa": [ "Janus Kinase Inhibitors [MoA]" ], "unii": [ "82S8X8XX8H" ] } }, { "drugcharacterization": "2", "medicinalproduct": "SYNTHROID", "drugstructuredosagenumb": "150", "drugstructuredosageunit": "004", "drugdosagetext": "150 ?G, QD", "drugindication": "MYELOFIBROSIS", "openfda": { "application_number": [ "NDA021402" ], "brand_name": [ "SYNTHROID" ], "generic_name": [ "LEVOTHYROXINE SODIUM" ], "manufacturer_name": [ "AbbVie Inc." ], "product_ndc": [ "0074-3727", "0074-4341", "0074-4552", "0074-5182", "0074-6594", "0074-6624", "0074-9296", "0074-7068", "0074-7069", "0074-7070", "0074-7148", "0074-7149" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "LEVOTHYROXINE SODIUM" ], "rxcui": [ "892246", "892251", "892255", "966158", "966171", "966185", "966191", "966201", "966205", "966218", "966220", "966221", "966222", "966224", "966225", "966247", "966248", "966249", "966250", "966251", "966253", "966270", "966271", "966282" ], "spl_id": [ "b85ab7fa-ba96-43cd-b736-44b3924e644c" ], "spl_set_id": [ "1e11ad30-1041-4520-10b0-8f9d30d30fcc" ], "package_ndc": [ "0074-4341-13", "0074-4341-90", "0074-4341-19", "0074-4341-72", "0074-4552-13", "0074-4552-90", "0074-4552-19", "0074-4552-11", "0074-4552-71", "0074-4552-72", "0074-5182-13", "0074-5182-90", "0074-5182-71", "0074-5182-19", "0074-5182-11", "0074-5182-72", "0074-6594-13", "0074-6594-90", "0074-6594-71", "0074-6594-19", "0074-6594-72", "0074-6624-13", "0074-6624-90", "0074-6624-19", "0074-6624-11", "0074-6624-71", "0074-6624-72", "0074-9296-13", "0074-9296-90", "0074-9296-19", "0074-9296-71", "0074-9296-72", "0074-7068-13", "0074-7068-90", "0074-7068-71", "0074-7068-19", "0074-7068-11", "0074-7068-72", "0074-3727-13", "0074-3727-90", "0074-3727-71", "0074-3727-19", "0074-3727-72", "0074-7069-90", "0074-7069-71", "0074-7069-19", "0074-7069-11", "0074-7069-72", "0074-7070-13", "0074-7070-90", "0074-7070-71", "0074-7070-19", "0074-7070-72", "0074-7148-90", "0074-7148-19", "0074-7148-71", "0074-7148-11", "0074-7148-72", "0074-7149-90", "0074-7149-19" ], "unii": [ "9J765S329G" ] } }, { "drugcharacterization": "2", "medicinalproduct": "METOPROLOL", "drugdosagetext": "12.5 BID", "drugindication": "BLOOD PRESSURE", "openfda": { "application_number": [ "ANDA078950", "ANDA091045", "ANDA202871" ], "brand_name": [ "METOPROLOL", "METOPROLOL TARTRATE" ], "generic_name": [ "METOPROLOL TARTRATE", "METOPROLOL" ], "manufacturer_name": [ "Baxter Healthcare Corporation", "Fresenius Kabi USA, LLC", "Alembic Pharmaceuticals Inc.", "Alembic Pharmaceuticals Limited" ], "product_ndc": [ "36000-033", "63323-660", "62332-112", "62332-113", "62332-114", "65219-665", "46708-290", "46708-291", "46708-292" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "INTRAVENOUS", "ORAL" ], "substance_name": [ "METOPROLOL TARTRATE" ], "rxcui": [ "866508", "866511", "866514", "866924" ], "spl_id": [ "5d975af3-d078-4130-9448-ed77123f1aac", "4066607a-15cb-42ac-999e-5254907dda5a", "c7738f42-299e-4bea-af50-778e069352f0", "ccb1a15e-c943-4042-ae46-550bdabfc96b", "f31d2aef-f902-4984-803c-5bdb015e9253" ], "spl_set_id": [ "09566368-f91d-43a3-b683-30c844fb125a", "be1c686e-37a5-4a53-945b-68a6ead35134", "24837d82-0f3f-4482-9af0-31e5f675c30f", "ccb1a15e-c943-4042-ae46-550bdabfc96b", "cb76a73f-549a-4170-b96a-f93ed7e09464" ], "package_ndc": [ "36000-033-10", "63323-660-01", "63323-660-05", "62332-112-30", "62332-112-31", "62332-112-91", "62332-113-30", "62332-113-31", "62332-113-91", "62332-114-30", "62332-114-31", "62332-114-91", "65219-665-01", "65219-665-05", "46708-290-30", "46708-290-31", "46708-290-91", "46708-290-10", "46708-290-71", "46708-291-30", "46708-291-31", "46708-291-91", "46708-291-10", "46708-292-30", "46708-292-31", "46708-292-91", "46708-292-10" ], "unii": [ "W5S57Y3A5L" ] } }, { "drugcharacterization": "2", "medicinalproduct": "EFFEXOR", "drugstructuredosagenumb": "75", "drugstructuredosageunit": "003", "drugdosagetext": "75 MG, QD", "openfda": { "application_number": [ "NDA020699" ], "brand_name": [ "EFFEXOR XR" ], "generic_name": [ "VENLAFAXINE HYDROCHLORIDE" ], "manufacturer_name": [ "Viatris Specialty LLC", "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc." ], "product_ndc": [ "58151-125", "58151-126", "58151-127", "0008-0836", "0008-0837", "0008-0833" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "VENLAFAXINE HYDROCHLORIDE" ], "rxcui": [ "313581", "313583", "313585", "729929", "729931", "729932" ], "spl_id": [ "2319042f-5d24-42d3-9b0a-8893bed66813", "3f8cf689-0fbb-4056-a85d-150dfd527313" ], "spl_set_id": [ "c848a5d8-ba94-4c84-80e3-0bf35fb8e32e", "53c3e7ac-1852-4d70-d2b6-4fca819acf26" ], "package_ndc": [ "58151-125-93", "58151-125-77", "58151-126-93", "58151-126-77", "58151-127-93", "58151-127-77", "0008-0837-20", "0008-0837-21", "0008-0837-22", "0008-0837-02", "0008-0837-03", "0008-0833-20", "0008-0833-21", "0008-0833-22", "0008-0833-02", "0008-0833-03", "0008-0836-20", "0008-0836-21", "0008-0836-22", "0008-0836-02", "0008-0836-03" ], "unii": [ "7D7RX5A8MO" ] } } ] } } ] }